alfentanil has been researched along with Crohn Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bovill, JG; Burm, AG; Gesink-van der Veer, BJ; Vletter, AA | 1 |
| Bovill, JG; Burm, AG; Gesink-van der Veer, BJ; Hennis, PJ | 1 |
2 other study(ies) available for alfentanil and Crohn Disease
| Article | Year |
|---|---|
Influence of Crohn's disease on the pharmacokinetics and pharmacodynamics of alfentanil.
Topics: Adult; Alfentanil; Anesthesia, Intravenous; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Half-Life; Humans; Intestines; Male; Middle Aged; Orosomucoid | 1993 |
Alfentanil requirement in Crohn's disease. Increased alfentanil dose requirement in patients with Crohn's disease.
Topics: Adjuvants, Anesthesia; Adolescent; Adult; Alfentanil; Anesthesia, Inhalation; Crohn Disease; Drug Administration Schedule; Female; Fentanyl; Humans; Laparotomy; Male; Middle Aged; Nitrous Oxide; Orosomucoid | 1989 |